Thank you, Mr. Chair.
As I said earlier, this is an always-evolving situation. It is evolving even now. Since we started this discussion a few hours ago, the Prime Minister made an important announcement. He announced that Pfizer would be delivering millions more doses in the spring. Deliveries that had been scheduled for the last quarter of the year are being moved up. We will see even more in the summer months.
The Prime Minister also said that we will soon share the schedule with the provinces and territories so they can prepare to get all those doses into people's arms. He also announced that we would receive an additional four million doses from Moderna and nine million doses from Pfizer, which will arrive over the summer. We are now on track to receive 84 million doses by the end of September from just these two manufacturers, Pfizer and Moderna.
Another point I want to make is that the big difference between other countries and Canada is that they had domestic capacity before the pandemic. This is to echo Dr. Powlowski's point about pharmaceutical manufacturers repeatedly pulling out of Canada on the Conservatives' watch. Remember that New Zealand, Australia, South Korea and Japan have barely even started vaccinating and are countries with an at-home industry. What are [Technical difficulty—Editor]? Minister Champagne announced on Tuesday that Canada has reached an agreement in principle with Novavax, directing that leading developer to manufacture their vaccine at the expanded Royalmount facility, starting potentially in late 2021.
The point is this, Mr. Chair. Not only has our government been able to adapt to this ever-changing situation, but in doing so we are also reversing the trend of manufacturers leaving Canada. We are rebuilding our own capacity to sustain ourselves. All Canadian vaccine developers supported by our government are making progress through their clinical trials. Medicago is launching phase two or three trials in November. This is all good work that is happening.
Thank you, Mr. Chair.